TriAnkle has been presented at the 5th OAFI Osteoarthritis Patients World held at the Axa Auditorium in Barcelona on October 14th and 15th.
The event, organized by Osteoarthritis Foundation International (OAFI), has already become a benchmark in the field of medicine and more specifically in the specialty of rheumatology. It brings together the most important rheumatological associations at an international level with the aim of promoting scientific research in the field of osteoarthritis, presenting new advances related to the treatment of pathology and promoting the empowerment of osteoarthritis patients to improve the quality of life of people who suffer from it.
In this context, Aina Pascual, from Science, Research & Innovation Department of OAFI Foundation, was in charge of presenting TriAnkle as “a project whose objective is to develop 3D bioprinted structures based on collagen and gelatin, functionalized with nanoencapsulated regenerative factors. In this way, it is intended to obtain a better and faster regeneration of injured collagen-rich tissues, such as ankle joints, improving the quality of life of patients“.
The day before the congress, it took place the 3rd OAFI Osteoarthritis Patients Pre-Congress in which researchers, health authorities and different companies and professionals in the field of rheumatology met. Professors Ali Mobasheri, President of OARSI, and Leigh F Callahan, Director of Osteoarthritis Action Alliance, as well as Aina Pascual, from Science, Research Innovation Department of OAFI, participated in the presentation: Pre & Clinical Research with OA Patients After Covid 19 Era.
